Hai Yuan E Guo Zhao Gao Fengqi Hu Li Lu
10.1159/000507877
Blood Purif
2020;49(6):761-764.
coronavirus disease 19 end-stage renal disease hemodialysis severe acute respiratory syndrome-cov-2
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/32340018/
Betacoronavirus / isolation & purification Coronavirus Infections / complications Pneumonia, Viral / complications Renal Dialysis / methods
Betacoronavirus / isolation & purification Coronavirus Infections / complications Pneumonia, Viral / complications Renal Dialysis / methods Case Reports Antiviral Agents / therapeutic use COVID-19 COVID-19 Drug Treatment COVID-19 Testing Clinical Laboratory Techniques Combined Modality Therapy Coronavirus Infections / diagnosis Coronavirus Infections / drug therapy Coronavirus Infections / prevention & control Coronavirus Infections / therapy Cross Infection / prevention & control Diabetic Nephropathies / therapy Disease Progression Fatal Outcome Humans Infection Control / methods Infectious Disease Transmission, Patient-to-Professional / prevention & control Kidney Failure, Chronic / therapy Lung / diagnostic imaging Male Medical Waste Disposal / methods Middle Aged Multiple Organ Failure / etiology Pandemics / prevention & control Patient Isolation Pharynx / virology Pneumonia, Viral / diagnosis Pneumonia, Viral / prevention & control Pneumonia, Viral / therapy Respiration, Artificial SARS-CoV-2 Symptom Assessment Tomography, X-Ray Computed Antiviral Agents Medical Waste Disposal
PMC7251582
32340018
Coronavirus Disease 2019 in a Hemodialysis Patient
2020